Our Year in Drug Discovery
In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere.
This year saw the launch of updates to our ultra fast screening technologies, new partnerships for automated synthesis, and a new and comprehensive solutions hub.
We invite you to look back at the key developments that shaped a successful 2025.
Swiftness Redefined: infiniSee 7.0
Launched in July, ‘Arke’ introduced a revolutionary database format for Chemical Spaces, cutting search times by 85%. It transforms standard hardware into high performance engines. Its infiniSee xREAL counterpart allowed users to explore the 4.4 trillion compound xREAL Space even more efficiently.
Launch of SYNPLE Space
In August, we brought automated synthesis to your fingertips. Whether using infiniSee or SeeSAR, you can now explore synthesizable SYNPLE compounds locally and securely, closing the loop from virtual design to physical vial.
Benchmarking Bioactive Diversity
Our August open access study revealed that combinatorial Spaces generally provide closer analogs and higher scaffold diversity than traditional libraries. We identified key “blind spots” to offer a roadmap for future development.
DrugSpace Symposium 2025
September’s DrugSpace Symposium united industry and academia. Topics ranged from molecular glue degraders to AI driven workflows. Full recordings of the sessions and the dedicated BioSolveITday are available.
Your Go-To Resource: Drug Discovery Solutions
From handling trillion sized Chemical Spaces to fine tuning fragment based design, our new Solutions hub offers tailored scenarios and detailed answers for every stage of your workflow.
Thank you for being part of our journey in 2025!
We look forward to another year of innovation and shared success.